Marks Gilbert Lynn

Director

Latest Insider Transactions

Showing 10 of 12 transactions (past 365 days)

ANTX
Director
Award
$0
3,775 shares @ $0.00
Filed 2026-04-11Trade 2026-04-10
An2 Therapeutics, Inc.
ANTX
Director
Disposition
$0
23,742 shares @ $0.00
Filed 2026-03-23Trade 2026-03-19
An2 Therapeutics, Inc.
ANTX
Director
Disposition
$0
10,665 shares @ $0.00
Filed 2026-03-23Trade 2026-03-19
An2 Therapeutics, Inc.
ANTX
Director
Disposition
$0
10,362 shares @ $0.00
Filed 2026-03-23Trade 2026-03-19
An2 Therapeutics, Inc.
ANTX
Director
Award
$40.5K
10,362 shares @ $3.91
Filed 2026-03-23Trade 2026-03-19
An2 Therapeutics, Inc.
ANTX
Director
Award
$41.7K
10,665 shares @ $3.91
Filed 2026-03-23Trade 2026-03-19
An2 Therapeutics, Inc.
ANTX
Director
Award
$92.8K
23,742 shares @ $3.91
Filed 2026-03-23Trade 2026-03-19
An2 Therapeutics, Inc.
ANTX
Director
Award
$0
20,400 shares @ $0.00
Filed 2026-02-23Trade 2026-02-20
An2 Therapeutics, Inc.
ANTX
Director
Award
$0
11,560 shares @ $0.00
Filed 2026-01-14Trade 2026-01-12
An2 Therapeutics, Inc.
ANTX
Director
Award
$0
10,367 shares @ $0.00
Filed 2025-10-14Trade 2025-10-10
An2 Therapeutics, Inc.

Want to see more transactions?

Sign up for free to unlock more insider transactions and create watchlists.

Marks Gilbert Lynn is a corporate insider with SEC Form 4 filings on record. No transactions have been reported in the past 12 months. Historical filings, if any, are searchable below.